VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,391,801 | -62.3% | 148,538 | -1.2% | 0.36% | -56.9% |
| Q2 2023 | $3,689,459 | +8.9% | 150,406 | +3.3% | 0.83% | +0.6% |
| Q1 2023 | $3,386,832 | +49.0% | 145,545 | +62.1% | 0.82% | +57.9% |
| Q4 2022 | $2,273,040 | +31.3% | 89,808 | 0.0% | 0.52% | +16.6% |
| Q3 2022 | $1,731,000 | -38.3% | 89,808 | -18.5% | 0.45% | -29.0% |
| Q2 2022 | $2,807,000 | +36.1% | 110,223 | +37.4% | 0.63% | +40.2% |
| Q1 2022 | $2,063,000 | +12.0% | 80,223 | +82.3% | 0.45% | +3.5% |
| Q4 2021 | $1,842,000 | – | 44,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |